UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

Of the Securities Exchange Act of 1934

 

Date of Report:  December 27, 2007

(Date of earliest event reported)

 

INSWEB CORPORATION

(Exact name of Registrant as specified in its charter)

 

Delaware

 

0-26083

 

94-3220749

(State or other jurisdiction of

 

(Commission file number)

 

(IRS Employer

incorporation or organization)

 

 

 

Identification Number)

 

11290 Pyrites Way, Suite 200

Gold River, California 95670

(Address of principal executive offices)

 

(916) 853-3300

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 8.01  OTHER EVENTS.

 

On December 27, 2007, Hussein A. Enan, Chief Executive Officer exercised and held 25,000 non-qualified shares of InsWeb Corporation common stock with an option price of $3.48 per share and a market value of $8.69 per share. Subsequent to this transaction, Hussein A. Enan holds 452,864 options of which 423,697 shares are fully vested.

 

 

2



 

SIGNATURE

 

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated January 3, 2008

INSWEB CORPORATION

 

(Registrant)

 

 

 

 

 

/s/ L. Eric Loewe

 

 

L.Eric Loewe

 

Senior Vice President and General Counsel

 

 

3